TOBI (tobramycin) ( DrugBank: Tobramycin )


1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis1

299. Cystic fibrosis


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01953367
(ClinicalTrials.gov)
September 20134/9/2013Bioequivalence and Safety of Vantobra and TOBI in Healthy SubjectsBioequivalence and Safety Study of Vantobra and TOBI Nebulizer Solutions in Healthy SubjectsCystic FibrosisDrug: Vantobra (tobramycin);Drug: TOBI (tobramycin)Pari Pharma GmbHNULLCompleted18 Years50 YearsBoth72Phase 1Germany